Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
4SCAR30
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR38
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR70
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
64cu-grip b
Renal Cell Carcinoma
Rahul Aggarwal
P1/2
CC
(45)
[68ga]ga-dpi-4452
Urothelial Carcinoma
ITM Oncologics GmbH
P1/2
CC
(45)
68ga-p15-041
Metastatic Prostate Carcinoma
Peking Union Medical College Hospital
P1/2
CC
(45)
a2/4-1bbl melanoma vaccine
Melanoma
Hadassah Medical Organization
P1/2
CC
(45)
a2b543
Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
ab-1001 gene therapy
Huntington Disease
AskBio France, SAS, a subsidiary of AskBio Inc.
P1/2
CC
(45)
ab-201
Gastric Cancer
GC Cell Corporation
P1/2
CC
(45)
Abbv-453
Plasma Cell Myeloma
AbbVie
P1/2
CC
(45)
Abemaciclib
MIT Family Translocation Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(45)
abx196
Hepatocellular Carcinoma
Abivax S.A.
P1/2
CC
(45)
Ace-86225106
Breast-Ovarian Cancer, Familial, Susceptibility To, 1
Acerand Therapeutics (Shanghai) Limited
P1/2
CC
(45)
Ace-86225106
BRCA2-Related Cancer Predisposition
Acerand Therapeutics (Shanghai) Limited
P1/2
CC
(45)
Acetazolamide
Melanoma
Obsidian Therapeutics, Inc.
P1/2
CC
(45)
Acetazolamide
Metastatic Melanoma
Obsidian Therapeutics, Inc.
P1/2
CC
(45)
ad1208
Neoplasm
Avelos Therapeutics Inc.
P1/2
CC
(45)
Adebrelimab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Sun Yat-sen University
P1/2
CC
(45)
Adg 106
Non-Small Cell Lung Carcinoma
National University Hospital, Singapore
P1/2
CC
(45)
Adv/Hsv-Tk
Anaplastic Astrocytoma
The Methodist Hospital Research Institute
P1/2
CC
(45)
ak129
Classic Hodgkin Lymphoma
Akeso
P1/2
CC
(45)
Aleta-001
Diffuse Large B-Cell Lymphoma
Cancer Research UK
P1/2
CC
(45)
Allocetra-Ots
Peritoneum Cancer
Enlivex Therapeutics RDO Ltd.
P1/2
CC
(45)
Allogeneic Adipose-Derived Mesenchymal Stem Cells
Erectile Dysfunction
The Methodist Hospital Research Institute
P1/2
CC
(45)
Showing 3351 to 3375 of 6,302 assets
Previous
Page 135 of 253
Next